BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:01 PM
 | 
Sep 09, 2009
 |  BC Extra  |  Company News

FDA panel backs HPV vaccines

FDA's Vaccines and Related Biological Products Advisory Committee voted in favor of approval of marketing applications from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and Merck & Co. Inc. (NYSE:MRK) for their respective HPV vaccines, Cervarix and Gardasil. GSK is seeking approval of a BLA for Cervarix to prevent cervical cancer and precancerous lesions....

Read the full 254 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >